TrialJAMA network open2022

Quality of Life Following Receipt of Adjuvant Chemotherapy With and Without Bevacizumab in Patients With Lymph Node-Positive and High-Risk Lymph Node-Negative Breast Cancer.

Shoshana M Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.